相关实验视频
Updated: Jul 15, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.6K
上腺体受体自身抗体和IgG子类:当前状态和未解决的问题
Akane Kawai1, Yuji Nagatomo1, Midori Yukino-Iwashita1
1Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.
Journal of cardiovascular development and disease
|September 27, 2023
概括
对β1-上腺素受体 (β1AR-AAb) 的自身抗体与扩张性心肌病 (DCM) 有关. 在β1AR-AAb中的IgG子类差异可能会影响心血管疾病的治疗反应和疾病进展.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 分子医学是分子医学.
背景情况:
- 对β1-上腺素受体 (β1AR-AAb) 的自身抗体与扩张性心肌病 (DCM) 有关,影响约40%的患者.
- 这些抗体可以诱导β1AR脱敏,心肌细胞亡和流入,导致心脏功能障碍和心律失常.
研究的目的:
- 研究β1AR-AAb IgG亚类在DCM病原和治疗反应中的作用.
- 探索β1AR-AAb IgG亚类对超越DCM的心血管疾病的潜在影响,包括心力衰竭与保存的射出分数.
主要方法:
- 对β1AR-AAb的现有临床研究和研究的审查.
- 分析β1AR-AAb的IgG子类之间的结构和功能差异.
- β1AR-AAb存在和IgG亚类与临床结果和治疗反应 (例如β阻塞疗法,免疫吸收) 的相关性.
主要成果:
- 对于DCM患者来说,免疫吸附的有效性可能取决于特定IgG子类的去除,而不仅仅是总IgG.
- 患者对β-阻断剂治疗的反应因β1AR-AAb的IgG亚类而异.
- IgG亚类的差异表明β1AR-AAb的不同作用机制.
结论:
- 需要进一步的研究,以了解β1AR-AAb IgG亚类在DCM中的致病作用.
- 研究β1AR-AAb IgG亚类可以为包括HFpEF在内的更广泛的心血管疾病提供新的见解.
相关概念视频
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
652
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
652
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
881
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
881
Sympathetic Signaling
1.0K
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
1.0K

